DARZALEX SC

Опис товару

About DARZALEX SC

DARZALEX SC is a medicine that contains the active ingredient DARATUMUMAB, a monoclonal antibody used in the treatment of certain types of cancer. Specifically, DARZALEX SC is used for the treatment of multiple myeloma, a type of blood cancer characterized by the proliferation of malignant plasma cells in the bone marrow. DARZALEX SC is administered via subcutaneous injection, providing a convenient and less invasive alternative to traditional intravenous administration.

Key Benefits & Uses

• Treatment of multiple myeloma in adult patients, in combination with other medications
• Monotherapy for the treatment of multiple myeloma in adult patients who have received at least three prior lines of therapy
• Induction treatment of multiple myeloma in adult patients who are eligible for autologous stem cell transplant

Active Ingredient & Action

DARATUMUMAB, the active ingredient in DARZALEX SC, works by binding to the CD38 protein on the surface of cancer cells, leading to their destruction. This mechanism of action helps to reduce the number of cancer cells in the body, thereby alleviating symptoms and slowing disease progression.

Important Notes

It is essential to follow the dosage and administration instructions provided by a healthcare professional. Patients should also be aware of potential side effects, such as infusion-related reactions, and report any concerns to their doctor. Additionally, DARZALEX SC may interact with other medications, so it is crucial to disclose all current medications and medical history to the treating physician.